ICLR · Intrinsic value
Is ICON Public Limited Company (ICLR) overvalued or undervalued?
As of Oct 19, 2026, TickerWorth's valuation lenses put ICON Public Limited Company (ICLR) at $71.11 – $206.33, too broad a range to say where the delayed market price of $168.79 sits in it, so we do not call it over- or undervalued. It is a model estimate, and every input behind it is sourced below.
Model by Miraaj Patel · generated from SEC filings and market data · Updated Oct 19, 2026 · How these pages are made
What is ICLR worth?
- Fair-value range
- $71.11 – $206.33
- Market price
- $168.79
- Gap to fair value
- —
- Verdict
- Too wide to call
Reverse DCF: Today's price implies revenue growth of 21.4% a year for 5 years; our model assumes 6.8% a year on average over the same horizon.
What is ICLR's TickerWorth Score?
Scores lower than most companies we compare it with
Compared with Healthcare companies in US
Its strongest point: recent price trend has been strong. Its weakest: profitability is weak.
- Value · 52 of 100
Cheaper than 52% of Healthcare companies in US
- Price vs worth · 30 of 100
- Quality · 31 of 100
More profitable than 31% of Healthcare companies in US
- Financial health · 31 of 100
Financially stronger than 31% of Healthcare companies in US
- Growth · 44 of 100
Growing faster than 44% of Healthcare companies in US
- Momentum · 65 of 100
Outperformed 65% of Healthcare companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
Why ICLR gets a range, not one number
At a recent price of $168.79, ICON Public Limited Company (ICLR) sits inside a range too wide to call either way: our valuation lenses put the business somewhere between $71.11 and $206.33 per share. They disagree too widely for us to state a single fair value. We publish the range rather than a midpoint because a number that precise would claim more than the methods can support. This is an educational model, not a price target or a recommendation.
Read the full reasoning
The valuation discounts ICON Public Limited Company's projected free cash flows at a weighted-average cost of capital (WACC) of 10.0%, with a long-run terminal growth rate of 2.5%. About 76% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 21.4% annual revenue growth for ICLR. Our base case instead compounds to about 6.8% a year over the same forecast, so the market is pricing in materially faster growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, ICLR's modeled DCF value ranges from about $44.22 to $124.76 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what ICON Public Limited Company would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of ICLR's intrinsic value. Figures update as new filings and prices come in.
Every input behind ICLR's DCF
| Input | Value |
|---|---|
| Base-year revenueICON plc FY2025 20-F (accession 0001628280-26-038487): us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, FY2025 full year. | $8,251,340,000 |
| Base EBIT marginICON plc FY2025 20-F (accession 0001628280-26-038487): us-gaap:OperatingIncomeLoss 442,846,000 / revenue 8,251,340,000 = 5.37%, FY2025. | 5.4% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | 10% → 8% → 7% → 5% → 4% |
| Risk-free rateLive feed — US 10-year Treasury yield (^TNX) | 5.3% |
| BetaLive feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) | 1.24 |
| Terminal growthESTIMATEAssumption — TickerWorth house default 2.5%, held below WACC | 2.5% |
| Diluted sharesICON plc FY2025 20-F (accession 0001628280-26-038487): WeightedAverageNumberOfDilutedSharesOutstanding = 78,965,385 shares, FY2025. | 79M |
| Market priceLast known price · as of 2026-10-19 20:15 UTC | $168.79 |
Change ICLR's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does ICON Public Limited Company do?
What does it do?
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It operates in the Diagnostics & Research industry (Healthcare sector), headquartered in Ireland. The company employs roughly 40,200 people.
How does it make money?
The business turns $8.3B in annual revenue into profit. Out of every $100 of sales, about $9 is left as operating profit (operating margin of 9.4%), after a 24% gross margin on the products/services it sells. After all costs, taxes and interest, 0.3% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks stretched: carries modest debt (0.4× equity), may struggle to cover its short-term bills (1.0× current ratio), and is currently profitable.
Who at ICLR filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| McCague Eugene Pacelli | Director | Option exercise | $409,283.70 | Form 4 for McCague Eugene Pacelli (opens sec.gov in a new tab) | |
| McCague Eugene Pacelli | Director | Open-market sale | $569,625.00 | Form 4 for McCague Eugene Pacelli (opens sec.gov in a new tab) | |
| Murphy Ronan Martin | Director | Option exercise | $629,328.70 | Form 4 for Murphy Ronan Martin (opens sec.gov in a new tab) | |
| Murphy Ronan Martin | Director | Open-market sale | $875,875.00 | Form 4 for Murphy Ronan Martin (opens sec.gov in a new tab) | |
| CLIMAX JOHN DR | Director | Option exercise | $629,328.70 | Form 4 for CLIMAX JOHN DR (opens sec.gov in a new tab) | |
| CLIMAX JOHN DR | Director | Open-market sale | $875,875.00 | Form 4 for CLIMAX JOHN DR (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Common questions
What is ICLR's intrinsic value?
TickerWorth's valuation lenses put ICON Public Limited Company (ICLR) between $71.11 and $206.33 per share, versus a market price of $168.79. They disagree too widely for us to state a single fair value, so we publish the range.
Is ICLR overvalued or undervalued?
At $168.79 the price sits inside a range too wide to call either way. We don't call ICLR overvalued or undervalued from a range this wide. This is an educational estimate, not advice.
What discount rate is used for ICLR?
A WACC of 10.0% and a terminal growth rate of 2.5%.
Is ICON Public stock undervalued?
TickerWorth's fair-value range for ICON Public Limited Company (ICLR) is $71.11 – $206.33 against a market price of $168.79. Too wide to call. We publish a range here, not one number, so we do not call it over- or undervalued. This is a model estimate, not investment advice.
ICON Public (ICLR) DCF valuation and fair value
Our fair-value range for ICON Public Limited Company (ICLR) is $71.11 – $206.33, built on a 10.0% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into ICON Public stock?
Today's price implies revenue growth of 21.4% a year for 5 years; our model assumes 6.8% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of $168.79. A model estimate, not investment advice.
ICON Public (ICLR) insider trading
The most recent insider filing (SEC Form 4) for ICON Public Limited Company (ICLR): McCague Eugene Pacelli, Director, option exercise on 2026-09-17. The latest filings are listed on this page. A disclosure, not a signal to trade.
Other ways into the coverage
Not investment advice. TickerWorth Score is a model output.
Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.